There are two kinds of videos for your viewing: short educational topics called Clinical Minutes (2-4 minutes long) and longer educational segments labeled Videos.
Physicians at John Muir Health were among the first in Northern California to offer patients new minimally invasive treatment options including transcatheter aortic valve replacement (TAVR) to treat aortic stenosis and MitraClip for patients suffering from mitral regurgitation (MR).
Clinical Minutes: Structural Heart Disease
Gary Gershony, MD, Interventional Cardiologist, discusses updates with Structural Heart Disease and outlines how the newest technologies to replace diseased aortic valves are benefiting patients who are very sick as well as those that are healthier.
Catheter Based Treatment of Structural Heart Disease (SHD)
Gary Gershony, MD, discusses currently available catheter therapies in the treatment of Structural Heart Disease (SHD).
Advances in Percutaneous Treatment of Severe Mitral Regurgitation
This video presentation provides a framework on how to approach evaluating mitral regurgitation: anatomy, diagnosis, and pathophysiology.
Aortic Stenosis: Diagnosis, Prognosis and Treatment Update
The John Muir Health Transcatheter Aortic Valve Replacement (TAVR) Team provide a joint presentation on the prevalence of Aortic Stenosis (AS) and the use of TAVR as a treatment for appropriate candidates.
Our Cardiovascular Valve Program is Here for You
John Muir Health is one of select hospitals accepting referrals of qualified patients for transcatheter aortic valve replacement (TAVR), an alternative to traditional surgical valve replacement to treat aortic stenosis.
Transcatheter Mitral Valve Repair with MitraClip® at John Muir Health The only approved alternative to Mitral Regurgitation (MR) Surgery. A Less-Invasive Treatment Option for At-Risk Patients.
Repair retains the heart’s natural shape and function better than replacement. Patients who undergo valve replacement must take blood thinners for the rest of their lives.
The Aortic Treatment Program was developed to provide diagnosis and treatment of life-threatening thoracic aortic syndromes, and specialized treatment of conditions that may not be immediately life-threatening, such as asymptomatic thoracic aneurysms.
Transcatheter Aortic Valve Replacement (TAVR) at John Muir Health: Fulfilling an Unmet Need for Treating Patients at Intermediate and Severe Surgical Risk for Aortic Stenosis
Aortic stenosis (AS) is a narrowing of the aortic valve, often caused by a build-up of calcium on the aortic valve leaflets.